Anion gap high is a condition that occurs when the levels of certain electrolytes in the bloodstream are out of balance. It is a common laboratory finding that can be indicative of a variety of underlying metabolic abnormalities. Anion gap high is also known as hyperchloremic metabolic acidosis or hyperchloremic acidosis. In this article, we will take a closer look at the link between metabolic abnormalities and anion gap elevations, and discuss the various causes of anion gap high.
An anion gap is a measure of the difference between the concentrations of certain electrolytes in the bloodstream. It is calculated by subtracting the concentrations of the major anions (chloride and bicarbonate) from the concentrations of the major cations (sodium and potassium). A normal anion gap is typically between 8 and 12 mmol/L. An elevated anion gap indicates that there is an imbalance between the concentrations of electrolytes in the blood.
Anion gap high can be caused by a variety of metabolic abnormalities. These abnormalities can be divided into three main categories: renal tubular acidosis, metabolic acidosis, and hyperchloremic acidosis.
Renal tubular acidosis (RTA) is a condition in which the kidneys are unable to excrete acid properly. This leads to an accumulation of acid in the bloodstream, which can cause anion gap high. RTA can be caused by a variety of conditions, including certain medications, chronic kidney disease, and inherited genetic disorders.
Metabolic acidosis is a condition in which the body produces too much acid, or is unable to effectively eliminate acid from the bloodstream. This can lead to anion gap high. Metabolic acidosis can be caused by a variety of underlying conditions, including diabetes, liver disease, and kidney failure.
Hyperchloremic acidosis is a condition in which the body produces too much chloride, or is unable to effectively eliminate chloride from the bloodstream. This can lead to anion gap high. Hyperchloremic acidosis can be caused by a variety of underlying conditions, including dehydration, certain medications, and certain medical procedures.
Anion gap high can be indicative of a variety of underlying conditions, and it is important for healthcare providers to be aware of the potential causes of anion gap high. An elevated anion gap can be a sign of metabolic acidosis, which can lead to a variety of serious complications, including kidney failure and coma. It is also important to note that anion gap high can be caused by a variety of conditions, and it is important to identify the underlying cause of the elevation in order to provide the most effective treatment.
Anion gap high is a common laboratory finding that can be indicative of a variety of underlying metabolic abnormalities. These abnormalities can be divided into three main categories: renal tubular acidosis, metabolic acidosis, and hyperchloremic acidosis. It is important for healthcare providers to be aware of the potential causes of anion gap high, as it can be indicative of a variety of serious conditions. Identifying the underlying cause of the elevation is essential in order to provide the most effective treatment.
1.
When Should Immunocompromised Individuals Receive a COVID Booster?
2.
Home Screening Appeals to Women Facing Healthcare Barriers
3.
Quality of Life Similar With Proton Beam Therapy vs IMRT for Prostate Cancer
4.
Prolonged Screen Time Linked to Sleep Issues in Preschoolers
5.
Precision Medicine in mHSPC: Integrating Novel Biomarkers, Imaging, and Emerging Targeted Agents
1.
Rehabilitation After Organ-Conserving Cancer Surgery
2.
Revolutionizing Oncology: AI in Radiology, Machine Learning in Pathology, and Deep Learning for Cancer Detection
3.
Artificial Intelligence for Bone Marrow Cellular Ecosystem Modeling
4.
Thyroid Cancer and Insulin Resistance: Unraveling the Complex Interplay for Better Patient Outcomes
5.
Mastering Breast Cancer Care in 2025: Diagnosis, Treatment, Education, and Innovation
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Navigating the Complexities of Ph Negative ALL - Part XIII
2.
Treatment Paradigm for Patients with R/R Adult B-cell ALL- Expert Discussions
3.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part I
4.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part III
5.
CNS Clarity from Day One: Rethinking Early Diagnostic Strategies in ALK+NSCLC
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation